youtube_live
Q3 2026 earnings • released • EPS beat +११.३८% • Revenue beat +७.३३%
See resultschevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ ३१.२८
arrow_upward
+६.३४%(+१.८६) 1D
नोभेम्बर ९, १४:४७:०१ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
US$ २९.३२
High
US$ ३१.४१
Low
US$ २८.९३
Mkt. cap
१.८७ अरब
Avg. vol.
१२.९३ लाख
Volume
५.२५ लाख
52-wk high
US$ ४५.९९
52-wk low
US$ २२.२४
EPS
-US$ ७.०१
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
Open
US$ २९.३२
High
US$ ३१.४१
Low
US$ २८.९३
Mkt. cap
१.८७ अरब
Avg. vol.
१२.९३ लाख
Volume
५.२५ लाख
52-wk high
US$ ४५.९९
52-wk low
US$ २२.२४
EPS
-US$ ७.०१
Beta
०.६६
Shares outstanding
५.९८ करोड
No. of employees
५४०
News stories
From web sources and news partners
24/7 Wall St.
·
४० मिनेट पहिले
Verizon’s Dividends Kept $1,000 Afloat at $1,580 While the S&P 500 Reached $3,910
Coinpaper
·
७ मिनेट पहिले
Tech Stocks Trade Cheaper Than S&P 500 for First Time Since 2017 as AI Selloff Reshapes Valuations
ChartMill
·
२ घण्टा पहिले
S&P 500 Top Movers: Today's US Session Gainers and Losers
TradingView
·
२ घण्टा पहिले
QUICK SPARK: Nvidia Stock Eyes Worst Day Against S&P 500 Since DeepSeek's Shock
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc